WHO ICTRP trial
Stimulation Therapy to Produce Tears for the Treatment of Dry Eye
ACTRN12613001110774 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12613001110774 |
|---|---|
| Public title | Stimulation Therapy to Produce Tears for the Treatment of Dry Eye |
| Scientific title | Neurostimulation to Increase Tear Production Measured Objectively via Schirmer Test in Adult Patients with Moderate to Severe Dry Eye Disease – A Multicenter Study |
| Primary sponsor | Oculeve, Inc. |
| Secondary sponsors | Five Corners Pty Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia;New Zealand |
| Conditions | Dry eye disease; Dry eye disease;Eye - Diseases / disorders of the eye;Eye - Normal eye development and function |
| Interventions | Arm 1: Neurostimulation device (EMS 2000) - Lacrimal gland neurostimulation. The current provided is approximately 1 milliamp with the patient controlling the amplitude with a knob. The recommended duration of treatment is approximately 30… |
| Registration date | Mar 10, 2013 |
| Target size | 60 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: